Anticonvulsant activity and monoamine oxidase inhibitory properties of substituted 1,2,4-triazoles.
Nine 5-(3,4,5-trimethoxyphenyl)-4-substituted aryl-3-hydrazinocarbonylmethylthio-4H-1,2,4-triazoles were investigated for their anticonvulsant and monoamine oxidase inhibitory properties. The protection afforded by these compounds at a dose of 100 mg/kg ranged from 20-90% against pentylenetetrazol-induced seizures and 20-40% against electric shock-induced convulsions. The degree of in vitro monoamine oxidase inhibition by substituted triazoles ranged from 41-80%, 18-36% and 20-40% using kynuramine, tyramine and 5-hydroxytryptamine as substrate, respectively. The approximate LD50 values of greater than 1000 mg/kg exhibited low toxicity of substituted triazoles.
D000818:Animals; D000927:Anticonvulsants; D005260:Female; D008297:Male; D051379:Mice; D008996:Monoamine Oxidase Inhibitors; D051381:Rats; D013329:Structure-Activity Relationship; D014230:Triazoles / Q000494:pharmacology*
D000927:Anticonvulsants; D008996:Monoamine Oxidase Inhibitors; D014230:Triazoles